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Deubiquitinating enzymes are now emerging as potential therapeutic targets that control many 
cellular processes, but few have been demonstrated to control cell motility. Here, we show 
that ubiquitin-specific protease 17 (usP17) is rapidly and transiently induced in response to 
chemokines sDF-1/CXCL12 and IL-8/CXCL8 in both primary cells and cell lines, and that its 
depletion completely blocks chemokine-induced cell migration and cytoskeletal rearrangements. 
using  live  cell  imaging,  we  demonstrate  that  usP17  is  required  for  both  elongated  and 
amoeboid motility, in addition to chemotaxis. usP17 has previously been reported to disrupt 
Ras localization and we now find that usP17 depletion blocks chemokine-induced subcellular 
relocalization of GTPases Cdc42, Rac and RhoA, which are GTPases essential for cell motility. 
Collectively, these results demonstrate that usP17 has a critical role in cell migration and may 
be a useful drug target for both inflammatory and metastatic disease. 
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T
he post-translational modification of proteins through ubiqui-
tination is critical for proper regulation of numerous intracel-
lular processes. Consequently, removal of ubiquitin from these 
modified proteins by deubiquitinating enzymes (DUBs) is also vital, 
and a growing body of evidence shows that these enzymes are essen-
tial for regulation of many cellular functions including transcription, 
DNA repair, cell-cycle progression and apoptosis1–3. The ubiquitin-
specific protease 17 (USP17) is an immediate early gene that belongs 
to a subfamily of cytokine-inducible DUBs. The murine members 
of this family were initially identified as cytokine-inducible genes4–7, 
as is the human orthologue USP17 (ref. 8). Specifically, USP17 is 
induced by IL-4 and IL-6, which regulate the growth and differentia-
tion of leukocytes8. More recently, we have demonstrated that USP17 
controls the function of the small GTPase Ras through abrogation of 
its post-translational processing and membrane localization9,10. We, 
along with others, have also postulated that USP17 regulates the cell 
cycle at G1/S phase, thus regulating cell proliferation11,12.
Chemotaxis, or cell migration, is an important cellular function 
in multicellular organisms for normal homeostasis and development, 
but it is frequently deregulated in disease states such as inflamma-
tion and metastatic cancer progression13,14. Two types of cell migra-
tion have been identified: mesenchymal (wherein cells are elongated 
and form focal adhesions)15,16 and amoeboid (wherein cells have a 
blebbing/rounded morphology, transient adhesions and increased 
velocity)17,18. The Rho family of GTPases, through cycling between 
the inactive GDP and active GTP state, has a predominant role in reg-
ulating these processes14,19. Their activation at the plasma membrane 
initiates signalling cascades and the control of cytoskeletal dynam-
ics. RhoA activity is elevated in blebbing cells and indeed localizes 
to  the  bleb-like  protrusions20,  whereas  mesenchymal  migration  is 
  characterized by Rac1 activation and decreased downstream activa-
tion of LIM kinase21,22. In addition, Cdc42 can induce both modes of 
migration23,24. As cells are able to alter their morphology and mode 
of migration depending on their environment, regulation of these 
processes is critical. Therefore, by inhibiting both mesenchymal and 
amoeboid migration, this may be a point of putative therapeutic inter-
vention for diseases such as metastatic cancer and inflammation.
As the Rho family of GTPases is known to be involved in migra-
tion,  and  USP17  was  shown  to  control  Ras  plasma  membrane 
localization10, we postulated that USP17 would similarly affect Rho 
GTPase localization and cell motility. Here, we show chemokine 
regulation of this DUB in both elongated and amoeboid motility. 
Moreover,  we  demonstrate  that  USP17  depletion  blocks  normal 
cytoskeletal  rearrangements  and  chemokine-induced  membrane 
localization of Rho GTPases. Therefore, USP17 is essential for the 
relocalization of Rho GTPases during normal cell motility.
Results
USP17 is a chemokine-inducible gene essential for chemotaxis. 
As USP17 has previously been shown to be inducible upon cytokine 
stimulation,  we  first  examined  whether  USP17  was  induced  in 
response to chemokines (Fig. 1). We found that USP17 expression 
was  rapidly  and  transiently  induced  in  human  peripheral  blood 
mononuclear  cells  (PBMCs)  following  stimulation  with  CXCL12 
(Fig.  1a,b).  At  30 min  after  stimulation,  mRNA  levels  increased 
dramatically, returning to baseline at 90 min (Fig. 1a), when the most 
prominent increase in protein levels was detected (Fig. 1b). Similar 
USP17 upregulation was observed in HeLa (Fig. 1c,d) and Jurkat 
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Figure 1 | USP17 expression is required for chemotaxis. Human PBmCs (a,b) or HeLa cells (c,d) were stimulated with CXCL12 (100 ng ml − 1) for the 
indicated times. USP17 mRnA expression was assessed by RT–PCR (a,c) and usP17 protein was determined by immunoprecipitation (IP), followed by 
immunoblotting (IB) (b,d). In mRnA images, β-actin was used as a loading control, whereas γ-tubulin was the control for western blotting. (e) Jurkat  
T cells were serum starved and then stimulated with CXCL12 (100 ng ml − 1) for 0, 5, 10 and 15 min. usP17 mRnA was analysed by RT–PCR. glyceraldehyde 
3-phosphate dehydrogenase (GAPDH) mRnA was also analysed as a loading control. Human neutrophils extracted from blood (f) or the monocytic cell 
line u937 (g) were stimulated with CXCL8 (100 ng ml − 1) for the indicated times. usP17 protein was immunoprecipitated then blotted for usP17. Whole-
cell lysates were analysed for γ-tubulin as a loading control. (h,i) HeLa cells were transfected with either scrambled shRnA, usP17 shRnA1 or CYLD 
shRnA (h) or scrambled and two additional shRnAs targeting usP17 (shRnA2 and shRnA3) (i). Cells were left unstimulated (grey bars) or stimulated 
with CXCL12 (20 ng ml − 1) (black bars) and chemotaxis was measured in modified Boyden chambers. RT–PCR was used to determine USP17 mRnA 
expression and β-actin was used as a loading control. Experiments were conducted in triplicate; values are mean ± s.e.m.; and statistical analyses are 
relative to untreated control by one-way analysis of variance. **P > 0.05.ARTICLE     
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T cells (Fig. 1e). However, USP17 upregulation was more rapid in 
both HeLa and Jurkat cells than in PBMCs, perhaps because PBMCs 
are a mixture of cell types of which only some respond to CXCL12. 
In addition, USP17 expression was also increased in neutrophils 
(Fig. 1f) and the human monocytic cell line U937 (Fig. 1g) when 
stimulated with CXCL8/IL-8. These results implied that USP17 may 
have an important role in inducing the chemotactic response in 
primary cells and in cell lines.
Therefore, to explore the importance of this DUB in chemok-
ine-induced cell migration, scrambled small hairpin RNA (shRNA) 
or  USP17  shRNA1-transfected  HeLa  cells  were  stimulated  with 
CXCL12, and migration was analysed using the modified Boyden 
chamber  assay.  USP17  depletion  consistently  ablated  CXCL12-
  stimulated  chemotaxis  to  levels  equivalent  to  unstimulated  cells, 
whereas an alternative shRNA targeting another DUB termed CYLD 
had no effect on chemotaxis (Fig. 1h), highlighting specificity for the 
role of USP17. Two additional USP17 shRNAs (USP17 shRNA2 and 
shRNA3) similarly reduced chemotaxis (Fig. 1i). Markedly reduced 
chemotaxis  was  also  observed  in  MDA-MB-231  and  U937  cells 
(Supplementary Fig. S1a and b, respectively). USP17 depletion by 
reverse transcription PCR (RT–PCR) is also illustrated. Moreover, 
overexpression of USP17 further enhances chemotaxis in MDA-
MB-231 cells (Supplementary Fig. S1c). Taken together, these data 
demonstrated that USP17 is required for directional migration.
To exclude the possibility that USP17 affects chemokine recep-
tor levels, we also examined the CXCL12 receptor, CXCR4, in HeLa 
cells and observed equivalent surface expression in the presence of 
USP17 shRNA1 or scrambled shRNA (Supplementary Fig. S2a). We 
further examined the external versus internal pools of CXCR4 and 
again  observed  no  significant  difference  between  scrambled  and 
USP17 shRNA1-transfected cells (Supplementary Fig. S2b). There-
fore, these finding clearly indicate that USP17 functions downstream 
of the receptor.
USP17 expression is also required for chemokinesis. In addition to 
chemotactic movement, cells can also migrate in a random undirec-
tional manner, termed chemokinesis25. Therefore, to establish whether 
USP17 expression was also essential for chemokinesis, the migration 
of Hut78 T cells, either transfected with scrambled or USP17 shRNA1 
bicistronic EGFP-expressing vectors, was examined. The cells were 
plated into wells coated with an antibody to the integrin leucocyte   
function associated-1 and images were captured over 90 min at 60 s   
intervals. USP17-depleted cells displayed a more rounded morphology 
and migration was decreased (Fig. 2a, Supplementary Movies 1 and 2). 
In triplicate experiments, quantification of Hut78 T cells with depleted 
USP17  showed   > 50%  reduced  chemokinesis  (as  well  as  decreased 
cell  velocity)  when  compared  with  scrambled  control  (Fig.  2b,c).   
Therefore, USP17 expression is not only required for chemokine-
induced directional migration but also for random cell motility.
USP17 is required for mesenchymal and amoeboid migration. 
As previously outlined, cells can undergo either mesenchymal or 
amoeboid  migration.  As  USP17  depletion  resulted  in  decreased 
chemokinesis, we next examined whether both forms of migration 
were being inhibited. In scrambled shRNA-transfected cells, the 
majority of cells were elongated, displayed a leading edge and a tail   
and,  following  chemokine  stimulation,  were  able  to  migrate   
(Fig.  3a,b  and  Supplementary  Movies  3  and  4).  However,  most 
USP17-depleted cells, did not form projections but instead produced 
blebs on the periphery of the cell (Fig. 3c,d and Supplementary   
Movies  5  and  6).  An  additional  shRNA  against  USP17  (USP17 
shRNA2) induced the same changes in morphology, whereas CYLD 
shRNA cells appeared unaffected, similar to scrambled shRNA cells 
(Supplementary Fig. S3). RT–PCR analysis on USP17 mRNA was 
  performed to confirm USP17 depletion compared with β-actin control 
(Fig. 3e and Supplementary Fig. S3e). The apparent alteration in cell   
shape was not as obvious in fixed cells, as those cells with a rounded   
morphology would have decreased adhesions and would be washed 
off  during  preparation.  Crucially,  however,  following  chemokine 
stimulation, USP17-silenced cells have decreased migration (Fig. 2). 
This suggests that depleting cells of USP17 blocks the cytoskeletal 
changes required for both elongated and amoeboid migration.
USP17 depletion blocks cytoskeleton rearrangements. As USP17 
knockdown inhibited cell migration, and cytoskeletal reorganiza-
tion is intricately involved in cell polarization and movement, we 
examined actin and tubulin polymerization as a potential mecha-
nism. HeLa cells were transfected with scrambled shRNA or USP17 
shRNA1, stimulated with CXCL12 and subsequently stained with 
α-tubulin (green) and phalloidin (red; detecting tubulin and actin 
polymerization, respectively) to visualize membrane ruffling and 
leading edge formation. Following stimulation, control cells dis-
played clear membrane ruffles (white arrow) indicative of lamel-
lipodial or leading edge formation, whereas USP17-depleted cells 
showed decreased actin and tubulin polymerization and markedly 
reduced ruffling (Fig. 4a). Membrane ruffling was quantified 2 and 
5 min  after  treatment  in  scrambled,  USP17  and  CYLD  shRNA-
transfected  cells  and  shown  graphically,  confirming  that  USP17 
was required (Fig. 4b and Supplementary Fig. S4). USP17 shRNA2 
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Figure 2 | USP17 depletion inhibits chemokinesis. Hut78 T cells were 
cotransfected with either scrambled shRnA or usP17 shRnA1 together with 
pmAX-GFP to determine transfected cells. Cells were allowed to adhere to 
culture plates coated with a CD11a/leucocyte function associated-1 antibody 
for 15 min before image acquisition using the In Cell Imager. Brightfield 
images were captured every 60 s for 90 min; fluorescent images at 488 nm 
were captured at 0 and 90 min to confirm transfection. scale bar, 20 µm.  
(a) Representative images of cells at 0, 30, 60 and 90 min (scale bar, 
20 µm). (b) Cell trajectories where each line indicates an individual cell’s 
migration. (c) A total of 60 cells were scored for distance and velocity and 
shown graphically. Each point represents one track, and the bar displays the 
median value. ***P > 0.005 as determined by one-way analysis of variance.ARTICLE

nATuRE CommunICATIons | DoI: 10.1038/ncomms1243
nATuRE CommunICATIons | 2:259 | DoI: 10.1038/ncomms1243 | www.nature.com/naturecommunications
© 2011 Macmillan Publishers Limited. All rights reserved.
also displayed similar results such that little actin polymerization 
was observed after chemokine stimulation (Supplementary Fig. S4). 
Results from triplicate experiments clearly indicated that depletion 
of USP17 blocks chemokine-dependent cytoskeletal reorganization 
during lamellipodia formation, and that this effect was specific for 
USP17 and not for DUBs in general.
USP17 is required for the membrane localization of GTPases. To 
further study the mechanism by which USP17 regulates cell migra-
tion, the localization of the Rho family of small GTPases was exam-
ined. Rho GTPases have a central role in the regulation of cell migra-
tion through remodelling of the cytoskeleton. We have previously 
implicated USP17 as a key regulator of GTPases Ras and RhoA in 
cell proliferation11. In addition, mesenchymal and amoeboid migra-
tion are differentially regulated by the Rho family of GTPases; RhoA 
has been demonstrated to induce blebbing, whereas Rac1 regulates 
elongated movement, and Cdc42 can induce both morphologies26. 
Therefore, we assessed the effect of USP17 depletion on the intracel-
lular localization and activation of Rac1, RhoA and Cdc42 in the 
context of cell migration. In unstimulated cells, these GTPases are 
localized primarily to the cytosolic regions of the cells. Following 
CXCL12 stimulation in control scrambled shRNA cells, the GTPases 
are transported to the plasma membrane (Fig. 5a–c white arrows). 
However, in USP17-depleted cells (shRNA1), the plasma membrane 
localization of Cdc42, Rac1 and RhoA was markedly blunted (Fig. 
5a–c, respectively). In addition, USP17 shRNA2 also resulted in a 
mislocalization of RhoA, whereas CYLD shRNA had no effect on its 
transport (Supplementary Fig. S5). The localization of endogenous 
RhoA, Cdc42 and Rac1 was also examined and a similar trend was 
observed such that USP17 was required for GTPase membrane local-
ization following chemokine stimulation (Supplementary Fig. S6). 
Fluorescent images were overlayed on brightfield images to confirm 
that the endogenous GTPases were indeed localized to the plasma 
membrane area, specifically in membrane ruffles (white arrows).
Recruitment of Rho GTPases to the plasma membrane allows 
them to interact with their respective GEFs, resulting in their activa-
tion and downstream signalling. Therefore, GTPase activation was 
also examined by GST-Rhotekin and GST-PAK pulldown assays (Fig. 
5d). In scrambled shRNA-transfected cells, we observed increased 
Cdc42, Rac1 and RhoA activation following CXCL12 stimulation 
(Fig.  5d).  However,  in  USP17-depleted  cells,  basal  constitutive 
GTPase activation was detected before stimulation and CXCL12 did 
not induce any detectable response (Fig. 5d). Again, USP17 shRNA2 
yielded similar results to USP17 shRNA1, whereas CYLD shRNA 
did not alter RhoA activation (Supplementary Fig. S7).
It is well documented that these GTPases are localized to mem-
brane ruffles of migrating cells27. Indeed, we observed Cdc42 and 
RhoA localization at these sites along with actin filaments following 
CXCL12 stimulation in control cells (Fig. 6a,b). Not surprisingly,   
in USP17-depleted cells, Cdc42 and RhoA were not localized to the 
edge of the cells, and no increase in short actin fibres, indicative 
of ruffling, was observed. Thus, USP17 is required for the proper 
localization of these GTPases to the leading edge and subsequent 
migration. We further confirmed that RhoA membrane localization 
was disrupted in USP17-depleted cells using total internal reflective 
fluorescence (TIRF), which allows selective detection of proteins 
specifically at the plasma membrane in living cells (Fig. 6c). Thus, 
these TIRF data add to the confocal data, demonstrating that USP17 
is required for the localization of GTPases to the membrane.
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Although USP17 depletion induced baseline activation of the 
GTPases  examined,  the  GTPases  did  not  localize  at  the  plasma 
membrane. To confirm that the mislocalized GTPases were indeed 
not  able  to  signal  downstream,  we  examined  the  activation  of 
various  well-characterized  proteins  normally  upregulated  when 
GTPases  are  membrane  activated.  Following  CXCL12  stimula-
tion when USP17 is depleted, we observed that activation of the 
downstream effectors PAK, β1 integrin and ERK1/2 was greatly 
diminished  compared  with  scrambled  shRNA-transfected  cells 
(Fig. 7). The finding that there was no increase in activation of effec-
tor proteins in USP17-depleted cells is in agreement with the data 
presented in Figure 5b, demonstrating no upregulation of GTPase 
activation in USP17-depleted cells. Therefore, USP17 is required for 
normal membrane localization of active GTPases and the upregula-
tion of downstream signalling pathways following stimulation and 
consequent cell motility.
Discussion
Deubiquitination enzymes have been demonstrated to be involved 
in multiple cellular processes1. The data presented here represent 
the first implication of their role in regulating both mesenchy-
mal and amoeboid cell motility. USP17 has been identified as an 
immediate early gene induced by cytokines5,6,8. However, here we 
have demonstrated that USP17 is also rapidly induced by chemok-
ines and USP17 expression is required for chemotaxis and chem-
okinesis, adding to its previously characterized role in cell-cycle 
progression8,11. The reduced actin and tubulin polymerization sug-
gests that USP17 is crucial for cell migration and reorganization of 
the cytoskeleton.
The ability of cells to change morphology and type of migration 
gives them the advantage of movement through various extracellular 
conditions, thus adapting to environmental constraints. Cell plasticity 
is well documented in cancer biology28 and its role in other pathologies 
such as inflammation has also been appreciated29,30. Interestingly,   
cells lacking USP17 have fewer cell protrusions, appear rounded,   
have  decreased  cytoskeleton  polymerization  and  have  markedly   
decreased  migration  distance  and  rate.  As  the  Rho  family  of 
GTPases has been shown to regulate the cytoskeleton and therefore 
cell motility22,31, we postulated that inhibiting GTPase membrane 
localization  may  be  the  mechanism  of  the  decreased  migration.   
Indeed, we have previously demonstrated that USP17 is implicated   
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Figure 5 | Knockdown of USP17 inhibits GTPase localization and 
activation. HeLa cells were transfected with scrambled shRnA or usP17 
shRnA1 along with GFP-tagged Cdc42 (a), Rac1 (b) and RhoA (c). Cells 
were either left unstimulated or stimulated with CXCL12 (100 ng ml − 1) for 
5 min and captured by confocal microscopy (Leica sP5). Arrows indicate 
sites of plasma membrane localization. scale bar, 20 µm. (d) Cells were 
transfected as in a–c, stimulated with CXCL12 (100 ng ml − 1) for 0, 0.5, 
2 or 5 min and analysed for GTPase activation by performing pulldown 
assays for the indicated GTPase. Pulldowns and whole-cell lysates were 
immunoblotted with Cdc42, Rac1 or RhoA antibodies as indicated. Data 
shown are representative of three experiments. ARTICLE
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in the mislocalization of Ras GTPase through the regulation of its 
processing and in particular the modulation of the protease RCE1 
(refs 10, 32); here, we illustrate that depletion of USP17 blocked 
RhoA,  Rac1  and  Cdc42  membrane  localization.  These  GTPases   
have been reported to be processed in a similar manner33 and could 
indicate that RCE1 regulation is responsible, although it is likely to 
not be the sole USP17 substrate and other targets may be involved. 
It is clear, however, that the active Rho GTPases are mislocalized in 
the absence of USP17 and when combined with the failure to activate   
their downstream effectors, could explain the defects in cytoskeletal 
reorganization and migration. RhoA or Rac1 are individually required 
for  mesenchymal  or  amoeboid  migration,  respectively;  therefore, 
preventing proper localization of both these GTPases along with 
Cdc42 would certainly inhibit motility23,24,34. In addition, the Ras 
GTPases also have a role in cell migration35, and we have previously 
demonstrated that USP17 is also able to regulate H-Ras and N-Ras 
membrane localization and activation10. The ability to modulate Ras 
and Rho GTPase family members through inhibition of USP17 may 
be a useful way to block both mesenchymal and amoeboid motility.
Interestingly, another DUB CYLD (cylindromatosis gene) has 
also  been  suggested  recently  to  regulate  cell  migration  through 
the GTPase Rac1 (refs 36, 37). It was demonstrated that inhibit-
ing CYLD resulted in decreased migration, which correlated with 
blunted  membrane  ruffling,  microtubule  shortening,  decreased 
polarization and reduced Rac1, but not RhoA or Cdc42 activity. 
This suggests that CYLD is able to regulate elongated cell motility, 
but not amoeboid migration. Our results using CYLD as a control 
demonstrated that CYLD depletion was not required for chemotaxis 
in our system, likely because these cells will still be able to undergo 
amoeboid migration. Therefore, CYLD and USP17 have distinct 
roles in regulating Rho GTPases and cell motility.
In summary, our findings show that expression of the DUB USP17 
is essential for chemotaxis and chemokinesis, and represents a poten-
tial new therapeutic target for regulating pathologies with aberrant 
cell motility. As our understanding of the function and regulation of 
these DUBs increases, the ability to target them and prevent disease 
is promising38. Indeed, inhibitors for DUBs such as USP7 are cur-
rently in development39. Previously, USP17 has been demonstrated 
to regulate both cell proliferation and G1/S cell-cycle progression 
and is increased in tumours11,32. Therefore, the dual role of USP17 in 
regulating cell growth and migration makes it an ideal candidate for 
the development of potential inhibitors in these diseases.
Methods
Plasmids. pSUPER-scrambled shRNA and pSUPER-USP17 shRNA1 (target 
sequence 5′-GCAGGAAGATGCCCATGAA-3′) were kind gifts from Dr Rene 
Medema (University Medical Center, Utrecht, the Netherlands). pRS-USP17 
shRNA2 (target sequence 5′-AAGAGCCACTCAGGAAAGCACCTTAGACC-3′) 
and pRS-USP17 shRNA3 (target sequence 5′-GATGATTTGGCTCCTGTGGCAA 
GACAGCT-3′) were purchased from Origene Technologies. pGFP-RS-USP17 
shRNA (target sequence 5′-GCAGGAAGATGCCCATGAA-3′) was purchased 
from Origene technologies. pCAGGS-eGFP-Cdc42, pCAGGS-eGFP-Rac1 and 
pCAGGS-eGFP-RhoA were kind gifts from Dr Michiyuki Matsuda (Osaka  
University, Osaka, Japan). pDQ-EV (His), pDQ-USP17 (His) and pDQ-USP17CS 
(His) were kind gifts from Dr Derek Quinn (Queen’s University, Belfast).
Cell culture and transfection. Hut78 and U937 cells were grown in RPMI 1640 
(PAA) and HeLa and MDA-MB-231 cells (American Type Culture Collec-
tion, Manassas, USA) in DMEM, supplemented with 10% FCS, 1% penicillin 
(10,000 U ml − 1)/streptomycin (10,000 µg ml − 1) and 1% l-glutamine (200 mM), 
grown at 37 °C in a 5% CO2 humidified incubator. Hut78 cells were transfected 
  using the Amaxa Nucleofector System (Lonza). U937, MDA-MB-231 and Hela 
cells were transfected with FuGENE6 (Roche) according to the manufacturer’s 
instructions. For those experiments with CXCL12 or CXCL8 stimulation, cells 
were rested for 12 h in DMEM without serum, then stimulated with the chemokine 
for the indicated times and concentrations indicated.
Primary cell isolation. Whole peripheral blood packs were donated by Northern 
Ireland Blood Service (Belfast, UK) or peripheral blood was drawn from healthy 
donors using 0.5 ml of 0.5 M EDTA (pH 8.0) as an anticoagulant. PBMCs and 
polymononuclear neutrophils (PMNs) from healthy volunteers were isolated from 
50 ml of whole blood by density gradient centrifugation at 650 g for 30 min over 
Ficoll (Amersham). PMNs were isolated by centrifugation and hypotonic lysis 
of erythrocytes. The cells were then washed twice at 290 g for 10 min with RPMI 
medium before counting.
RT–PCR. mRNA was extracted from cells using STAT60 reagent (Biogenesis), and 
RNA isolation was performed according to the manufacturer’s instructions.  
RT–PCR analysis of 1 µg total RNA was performed using the OneStep RT–PCR 
kit (Qiagen) according to the manufacturer’s instructions, and separated on 1% 
agarose gels11. The primer sets used were USP17 forward 5′-CAGTGAATTCGT 
GGGAATGGAGGACGACTCACTCTAC-3′ and USP17 reverse 5-AGTCATC 
GATCTGGCACACAAGCATAGCCCTC-3′, and β-actin forward 5′-GGACTTC 
GAGCAAGAGATGG-3′ and β-actin reverse 5′-AGCACTGTGTTGGCGTACAG-3′.
Immunoprecipitation and immunoblotting. Cells were washed once with 
ice-cold PBS and resuspended in 1% Triton lysis buffer containing protease 
inhibitors (1 mM Na3V04, 10 µg ml − 1 leupeptin, 10 µg ml − 1 aprotinin and 1 mM 
phenylmethylsulphonyl fluoride). Where indicated, cells were immunoprecipi-
tated using the monoclonal USP17 antibody (Fusion Antibodies). Immuno-
precipitations or whole-cell lysates (IB) were separated by SDS polyacrylamide 
gel electrophoresis, transferred to polyvinylidene difluoride membrane and 
probed with the appropriate antibodies. Antibodies used are listed in Supplemen-
tary Table S1. Proteins were detected using the enhanced chemiluminescence  
detection method (Amersham), exposed using the ChemiDoc XRS imaging  
system (Bio-Rad) and analysed with The Discovery Series software from  
Quantity One version 4.5.0 (Bio-Rad).
GTPase activation pulldowns. Cells were washed once with ice-cold PBS and 
lysed in 200 µl lysis buffer (50 mM Tris-HCl, pH 7.5, 1% Triton X-100, 100 mM 
NaCl, 10 mM MgCl2, 5% glycerol, 1 mM Na3VO4) containing protease inhibitors 
(1 mM Na3V04, 10 µg ml − 1 leupeptin, 10 µg ml − 1 aprotinin and 1 mM phenylmeth-
ylsulphonyl fluoride). Cell lysates were incubated at 4 °C for 1 h with GST-fusion 
protein (GST-PAK for CDC42 and Rac1 of GST-Rhotekin for RhoA) coupled to 
glutathione-sepharose beads (Amersham Biosciences) as described previously11. 
Protein was run on SDS polyacrylamide gel electrophoresis gels and analysed 
as indicated in the previous section. Active GTPases and whole-cell lysates were 
detected by immunoblotting with the appropriate antibodies.
Boyden chamber cell migration assay. MDA-MB-231 and HeLa cells were plated 
in 12 mm-diameter Transwells (Corning Costar), transfected with the indicated 
plasmids and stimulated with 20 ng ml − 1 CXCL12 (PeproTech). Plates were then 
incubated at 37 °C in 5% CO2 for 20 h. Migrated cells at the bottom of the top 
chamber were fixed for 10 min in methanol, stained with crystal violet solution 
(0.05% crystal violet and 25% methanol), washed and air-dried for 1 h. The filters 
were then destained with cell migration destaining solution (1:1 ethanol: 0.2 M 
sodium citrate) and measured using a microplate reader read at A570.
Fixed cell confocal imaging. Cells were seeded and transfected on LabTek II, 
CC2-treated chamber slides as described, fixed in 4% paraformaldehyde for 
20 min, permeabilized with 0.5% Triton for 5 min and stained with the indicated 
antibodies and/or costain, which are listed in Supplementary Table S2. Slides were 
viewed using a Leica TCS SP5 DMI6000 CS Confocal Microscope (Leica) using 
the following lasers: ultraviolet (355 nm), Argon (488 nm) and HeNe (543 nm, 
633 nm). Fluorescent images were captured with a 40× lens zoomed in 1–3× with a 
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Figure 7 | USP17 depletion results in blunted downstream signalling. 
HeLa cells were transfected with either scrambled shRnA or usP17 
shRnA1  and stimulated with CXCL12 (100 ng ml − 1) for 0, 0.5, 2 or 5 min. 
Protein was collected and whole-cell lysates were immunoblotted for 
pPAK, total PAK, active β1 integrin, total β1 integrin, pERK1/2 and total 
ERK1/2 as indicated.ARTICLE     
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1,024×1,024 frame and 400 Hz scanning speed. Images were analysed using Leica 
LAS AF software (Leica) and ImageJ (NIH).
Live cell migration assay. Hut78 migration assays were carried out in nunclon 
96-well plates. On the evening before the migration, a goat anti-mouse capture an-
tibody (Sigma) was added to the wells and left overnight at 4 °C. Wells were washed 
and incubated with a mouse anti-CD11a antibody (Monosan Clone SPV-L7) for 
3 h at 37 °C. Wells were washed three times, and 10,000 cells per 100 µl were added 
to the wells and left for 15 min before beginning live cell image capture using the 
IN Cell Imager 1000 (GE Healthcare). Brightfield images were captured every 60 s 
for 90 min and images at 480×535 nm were taken at 0 and 90 min and cell migra-
tion was measured using ImageJ software (NIH).
Alternatively, HeLa cells were plated onto glass-bottomed 35 mM µ-dishes 
(Ibidi) and transfected as previously described. At 48 h post infection, images were 
captured every 15 s for 10 min using a Leica TCS SP5 Confocal Microscope and 
analysed using ImageJ software (NIH).
TIRF microscopy. HeLa cells were plated onto 35 mM MatTek glass-bottomed 
dishes (MatTek), and transfected with GFP-tagged RhoA along with scrambled 
shRNA, USP17 shRNA1 or USP17 shRNA2. At 48 h post transfection, cells were 
serum starved for 12 h. Brightfield and TIRF images were captured using the Nikon 
Eclipse Ti both before and after stimulation with CXCL12. TIRF settings were kept 
at 200 ms exposure and gain 10 and brightfield at 100 ms exposure and gain 10 at 
60× magnification. Analysis for Green TIRF fluorescence was performed using NIS 
Elements AF 3.1 Software. 
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